Editor in Chief Dr KK Aggarwal, Padma Shri Awardee                                                                               Dated:13 March,2020

Sharing data of coronavirus on daily basis has created panic in country: IMA

Amid rising cases of novel coronavirus in the country, the Indian Medical Association (IMA) has said sharing data of infected people on a daily basis with the public has created panic across the country.

Amid rising cases of novel coronavirus in the country, the Indian Medical Association (IMA) has said sharing data of infected people on a daily basis with the public has created panic across the country. It also appealed to the government to "classify the data" of the pandemic and take appropriate action with "clinical precision".

"Doctors and hospitals remain a silver lining in otherwise clueless situation for the common man," the doctors' body said while appealing to every doctor to function as a source of credible information in their locality and instil confidence and trust in the public....read more


Time for containment, don't allow infection to come to your country, we are not at mercy of virus

CMAAO COVID-19
It’s official: COVID 19 is now a pandemic but not the time for countries to move to mitigation, Must still try to suppress transmission, continue with containment efforts

All Travel from Europe to the United States suspended for 30 days, ban will not apply to the UK
India isolates itself
Total cases 73
Serious: Zero
Super spreader: Zero....read more


To flatten the curve: Decontaminate surfaces, wash hands and stay away from people with fever, cough

Here is how CMAAO countries should flatten the curve and make it blue from red
Decontaminate surfaces, wash hands and stay away from people with fever and cough
Once it is a pandemic, for example India has 60 cases and possible 1000 contacts under observation. Using 1:1 isolation method kit will be possible to stop formation of clusters. With ban of International travel new cases will not come and India can safely declare itself free of the virus. To help the government....read more


COVID 19 PANDEMIC

But not the time for countries to move to mitigation, Must still try to suppress transmission, continue with containment efforts
All Travel from Europe to the United States suspended for 30 Days, Ban will not apply to the UK
INDIA ISOLATES ITSAELF
Trump had said earlier: "I am fully prepared to use the full power of the Federal Government to deal with our current challenge of the CoronaVirus!" [source]....read more


Swayambhu or self-manifested

Swayambhu or ???????? is a Sanskrit word that means "self-manifested", "self-existing" or "that is created by its own accord". In Sikh prayer it is called Ajuni Saibham. In Tibetan, this word appears as "Rangjung".
The word Swayambhu is used to describe a self-manifested image of a deity, otr ku (Tibetan) which was not made by human hands, but instead is naturally arisen, or generated by nature....read more


How Corona Aware Are You

Health Sutras By Dr K K Aggarwal

Did you know a mosquito bite can kill a human being?


Medbytes

       


Healthcare News Monitor

Coronavirus: China stalls supplies, India faces anti-retroviral shortage
The Times of India- Sushmi Dey

Local drug makers are facing supply disruptions from China for some active pharmaceutical ingredients (APIs) that are used in manufacturing medicines for treating coronavirus, industry executives said. These medicines - antiretrovirals - are manufactured by around five major pharma companies in India and are supplied to various other countries apart from local use. While in the wake of global coronavirus outbreak, the demand for such drugs have surged, China is holding back supplies to meet its own demand. “Recently, some of the scheduled consignments have not arrived and an informal communication indicates China is holding back supplies for certain APIs and intermediates that are used particularly in coronavirus drugs,” a senior executive told TOI. Coronavirus outbreak: Complete coverage Manufacturers said they presently have stocks to treat around one lakh patients but if the situation worsens, it may be a cause for worry as China is the only supplier of these APIs to India and there is no alternative source. Lopinavir and ritonavir combination - usually a second line HIV medication – are being used in many countries to treat severe cases of coronavirus. India too used these drugs in the treatment of two Italian patients — a couple on a tour of India — who tested positive for Covid-19 in Jaipur. Health ministry officials said on Thursday the decision to administer a combination of anti-HIV drugs- lopinavir and ritonavir- on a coronavirus-infected elderly Italian couple at a Jaipur hospital was “initially taken locally”. The hospital has been asked to inform the health ministry and the Indian Council of Medical Research (ICMR) before administering the drug combination on Covid-19 patients in future.

Covid-19 Impact: Fears of Chinese API shortage hurt pharma players
The Economic Times- Divya Rajagopal

Covid-19 fears triggered a selloff in pharma stocks on Thursday, with the BSE Healthcare Index mirroring the more than 8 per cent decline in the benchmark Sensex. Glenmark Pharmaceuticals was the biggest loser on the healthcare index, with the Mumbai-based company’s shares plunging almost 23 per cent, followed by Wockhardt, RPG Lifesciences and Aurobindo Pharma. The fall came even as India Ratings said the credit outlook for Indian pharma companies remains positive in the near-term despite the industry’s “heavy reliance” on Chinese active pharmaceutical ingredients and intermediates. Data from the All India Chemists and Druggists Association showed the domestic pharma industry grew 12 per cent in February compared with 7 per cent in the previous month. The healthcare index dropped 8.3 per cent, while the Sensex retreated 8.2 per cent after India imposed curbs on international arrivals by suspending most visas until April 15. The US banned travel from mainland European countries in an attempt to halt the spread of the coronavirus. For the pharma sector, which is overly dependent on China for ingredients and intermediary products needed to make medicines, a shortage coupled with India’s export restrictions, has been an overhang. Analysts at India-Ra said if Covid-19 is not contained in the next three months, the extent of supply disruptions might be greater than in 2017, when several small and medium Chinese companies had halted production.

Indian-origin doctor from Canada tests positive for coronavirus, kept in isolation at Lucknow’s KGMU
Hindustan Times- PTI

A 35-year-old Indian-origin doctor from Canada, who came to visit her relatives here, has been tested positive for novel coronavirus (COVID-19) at the KGMU and her samples have been sent to Pune’s National Institute of Virology for reconfirmation, a senior doctor said on Thursday. She has been kept in an isolation ward while her husband, who had accompanied her, has also been tested but has been found to be negative in the two tests conducted on him, Professor D Himanshu of King George’s Medical University’s Medicine Department said. The 35-year-old doctor of Indian origin is based in Toronto, Canada and had arrived here on March 8. She was tested positive on Wednesday night and her samples have been sent for reconfirmation to NIV, Dr Himanshu said. Though she did not show any symptoms during screening at the Lucknow airport, she developed fever and cough later and contacted the doctors at KGMU, he said. The doctors are also identifying those who had interacted with her between March 8 and 11 and they will all be tested, he added. “Her husband is also under observation in the hospital but he will be discharged by evening today,” Dr Himanshu said. KGMU spokesman Dr Sandip Tiwari said a total of 300 samples from across the state have been tested in the lab in KGMU hospital and besides the seven cases of Agra, the latest case of the Canadian doctor has been found to be positive.

First coronavirus death in India: 76-year-old who died in Karnataka had Covid-19, says state govt
India Today- Nagarjun Dwarakanath

India has registered the first confirmed case of death due to novel coronavirus. A 76-year-old man from Karnataka's Kalaburgi who passed away recently has been tested positive for Covid-19. The doctors had suspected that the man had coronavirus, however, the test had not confirmed it. In an official notification, a senior health official in Karnataka government Dr Suresh Shastri said that the lab test has confirmed that the deceased man had Covid-19. "The 76-year-old man from Kalburgi who passed away and was a suspected COVID 19 patient has been confirmed for COVID 19. The necessary contact tracing, isolation and other measures as per protocol are being carried out. Telangana government has also been informed since he went to a private hospital there," Dr Suresh Shastri said. The same information was also shared by Karnataka health minister B Sriramulu. A senior Union health ministry official said in New Delhi that the death of the man had visited Saudi Arabia from January 29 to February 29. The official said the man had reached in Hyderabad on February 29 and went to Kalaburagi in Karnataka. State Joint Director (Communicable Diseases) BG Prakash Kumar said all protocols were followed for disposal of the body. "The body is disinfected completely and disposed of as per the Government of India guidelines," he added when asked to elaborate on the protocols. He said the Telangana government has also been informed as the man had gone to a private hospital in Hyderabad earlier.
While announcing the death of the man on Tuesday, the state authorities had said the exact cause his death was being ascertained. According to the Union health ministry official, "While he was asymptomatic on his return (from Saudi Arabia), he developed symptoms of fever and cough on 6th March. One private doctor visited him at his home and treated him there."